ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ATXI Avenue Therapeutics Inc

4.5147
0.00 (0.00%)
2024年4月30日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Avenue Therapeutics Inc ATXI NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 4.5147 09:00:00
始値 安値 高値 終値 前日終値
4.5147
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2921:00GLOBEAvenue Therapeutics Announces Exercise of Warrants for $4.4..
2024/4/2420:30GLOBEAvenue Therapeutics Announces Reverse Stock Split
2024/3/2521:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
2024/3/1905:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
2024/3/1521:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
2024/3/1121:00GLOBEAvenue Therapeutics to Present BAER-101 Preclinical Data at..
2024/3/0906:31EDGAR2Form PRE 14C - Other preliminary information statements
2024/3/0906:15EDGAR2Form 8-K - Current report
2024/2/2222:30GLOBEAvenue Therapeutics Announces Publication in Drug..
2024/2/0214:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/2922:00EDGAR2Form DEF 14C - Other definitive information statements
2024/1/2506:11EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/1/1807:05EDGAR2Form PRE 14C - Other preliminary information statements
2024/1/1220:01EDGAR2Form 8-K - Current report
2024/1/1122:00GLOBEAvenue Therapeutics to Present at Sidoti January Micro-Cap..
2024/1/0907:28EDGAR2Form 8-K - Current report
2024/1/0523:15GLOBEAvenue Therapeutics Enters into Warrant Exercise..
2024/1/0422:30GLOBEAvenue Therapeutics Reaches Final Agreement with the U.S...
2024/1/0222:30GLOBEAvenue Therapeutics Announces Completion of Enrollment in..
2023/12/1406:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/12/1406:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0122:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
2023/11/2906:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/11/2906:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/2503:19EDGAR2Form 8-K - Current report
2023/11/1406:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1406:10EDGAR2Form 8-K - Current report
2023/11/1406:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0305:10EDGAR2Form 8-K - Current report
2023/11/0304:00GLOBEAvenue Therapeutics Announces Closing of $5.0 Million Public..
2023/11/0222:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2023/10/3122:15GLOBEAvenue Therapeutics Announces Pricing of $5.0 Million Public..
2023/10/0606:05EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
2023/9/3006:23EDGAR2Form S-1/A - General form for registration of securities..
2023/9/2905:25EDGAR2Form 8-K - Current report
2023/9/2805:03EDGAR2Form 8-K - Current report
2023/9/1906:18EDGAR2Form S-1 - General form for registration of securities under..
2023/9/0905:15EDGAR2Form 8-K - Current report
2023/9/0521:30GLOBEAvenue Therapeutics to Present at H.C. Wainwright 25th..
2023/8/1505:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
2023/8/1205:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:20EDGAR2Form 8-K - Current report
2023/8/1105:15GLOBEAvenue Therapeutics Reports Second Quarter 2023 Financial..
2023/8/0121:30GLOBEAvenue Therapeutics Announces High Potency and Full Efficacy..
2023/7/2721:30GLOBEAvenue Therapeutics Announces First Patient Dosed in Phase..
2023/7/2521:30GLOBEAvenue Therapeutics Announces Agreement with the FDA on the..
2023/7/2205:37EDGAR2Form 8-K - Current report
2023/7/0605:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0605:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0605:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock